Introduction
============

Extracellular polysaccharides or exopolysaccharides (EPSs) are high-molecular weight sugar-based polymers that are synthesized and secreted by many microorganisms. The importance of their production has been studied in many bacteria. Typically EPSs play a role in bacterial adaptation to different stress conditions, being involved in the establishment of symbiotic and pathogenic relationships with hosts and being suggested to be a major component of biofilm mature structures. The genus *Burkholderia* also has the ability to produce EPS and at least seven different exopolysaccharides have been identified and their structure determined (Table [1](#T1){ref-type="table"}). Some strains produce a single exopolysaccharide while others produce mixtures. For example, *Burkholderia cepacia* IST408 produces cepacian only (Cescutti et al., [@B7]), but *Burkholderia cenocepacia* C9343 produces simultaneously PS-I, cepacian (PS-II), and α-1,6-glucan (Conway et al., [@B11]). The most common EPS produced by *Burkholderia* is cepacian and has been identified in different species, including environmental isolates associated with plants and in both clinical and environmental isolates from *B. cepacia* complex (*Bc*c; Ferreira et al., [@B16]; Hallack et al., [@B21]). Furthermore, genes encoding proteins involved in cepacian synthesis are well conserved among *Burkholderia*, suggesting that cepacian is a common feature among the genus (Ferreira et al., [@B16]). Cepacian is composed of a branched acetylated heptasaccharide repeat-unit with [d]{.smallcaps}-glucose, [d]{.smallcaps}-rhamnose, [d]{.smallcaps}-mannose, [d]{.smallcaps}-galactose, and [d]{.smallcaps}-glucuronic acid in the ratio of 1:1:1:3:1 (Cerantola et al., [@B5]; Cescutti et al., [@B7]).

###### 

**Structural formula of the exopolysaccharide repeated units described in the literature**.

  EPS/species                            Structure                      Observations                                                                                                                                                               Reference
  -------------------------------------- ------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------
  Cepacian (PS-II)/*Bc*c and non-*Bc*c   ![](fcimb-01-00016-i001.jpg)   Environmental and clinical isolates; *bce*-I and *bce*-II genes present in most *Burkholderia* species; number of acetyl groups is strain dependent (two to four per RU)   Cerantola et al. ([@B5]), Cescutti et al. ([@B7]), Hallack et al. ([@B21])
  PS-I/*B. cepacia*                      ![](fcimb-01-00016-i002.jpg)   Clinical isolate                                                                                                                                                           Cerantola et al. ([@B6])
  Levan/*B. cepacia*                     ![](fcimb-01-00016-i003.jpg)   This strain produces an EPS mixture that includes levan                                                                                                                    Cescutti et al. ([@B9])
  EPS A/*B. kururiensis*                 ![](fcimb-01-00016-i004.jpg)   Endophytic diazotrophic species                                                                                                                                            Mattos et al. ([@B27])
  EPS B/*B. kururiensis*                 ![](fcimb-01-00016-i005.jpg)   EPS B composed of a mixture of two polymers: cepacian and the octasaccharide polymer, differing by the presence of a terminal glycosyl residue                             Hallack et al. ([@B21])
  EPS/*B. pseudomallei, B. cepacia*      ![](fcimb-01-00016-i006.jpg)   One acetyl group per RU                                                                                                                                                    Nimtz et al. ([@B32]), Cescutti et al. ([@B9])
  EPS/*B. caribensis*                    ![](fcimb-01-00016-i007.jpg)   Isolated from rhizosphere and important for soil aggregation                                                                                                               Vanhaverbeke et al. ([@B48])

*Main species from where different EPS were identified and relevant information associated with strain source or EPS characteristics is provided. Gal, galactose; Glc, glucose; GlcA, glucuronic acid; Man, mannose; Rha, rhamnose; Fru, fructose; Kdo, 3-deoxy-D-manno-2-octulosonic acid; 6dTal, 6-deoxy-talose; *O*Ac, acetyl substituent; RU, repeat-unit*.

Cepacian production depends on external factors. For instance, many strains unable to produce exopolysaccharide on LB medium start to over-produce it in rich glucose- or mannitol-based medium, such as S, SM, or YEM media (Richau et al., [@B36]; Bartholdson et al., [@B1]; Zlosnik et al., [@B55]). Also, the type of EPS produced depends on external growth conditions as demonstrated for the production of EPS A and EPS B by *Burkholderia kururiensis* (Table [1](#T1){ref-type="table"}; Hallack et al., [@B21]). These observations indicate that EPS production by *Burkholderia* is tightly regulated as a response to external conditions, which can be crucial in bacterial colonization and adaptation to different environments and hosts. Since cepacian is the major EPS produced by *Burkholderia*, this review will focus on the present knowledge concerning cepacian biosynthesis, regulation, and possible importance in bacteria lifestyle.

Genes and Proteins Involved in Cepacian Biosynthesis
====================================================

Genes involved in cepacian biosynthesis are located within *bce*-I and *bce*-II gene clusters (Figure [1](#F1){ref-type="fig"}A; Moreira et al., [@B30]; Ferreira et al., [@B16]). Comparative genomic studies indicate that the two clusters are present in all sequenced *Burkholderia* genomes, with the exception of the intracellular endosymbiotic *Burkholderia rhizoxynica* HKI 454 with both gene clusters absent and *Burkholderia mallei* having only *bce-II*. Isolates from these two species suffered genomic size reduction and loss of many genes as indicated by the 3.6-Mbp of *B. rhizoxynica* genome and the 5.2- to 5.9-Mbp of *B. mallei* genomes in comparison with the 6.3- to 9.7-Mbp of the genomes from the remaining *Burkholderia* species. Depending on the species, the two gene clusters can be located together in the same genomic region or separated by hundreds of kilobase pairs (Ferreira et al., [@B16]). The phylogenetic tree based on the concatenation of all Bce protein sequences showed three distinct groups (Figure [1](#F1){ref-type="fig"}B). Group I includes clinical and environmental isolates from the *Burkholderia cepacia* complex, all of them having the two *bce* clusters located apart from each other. Group II contains animal and plant pathogenic non-*Bc*c isolates also having the two clusters in different genomic locations. Group III harbors non-pathogenic rhizosphere and plant-associated strains having *bce-I* and *bce-II* gene clusters together. The rice pathogen *Burkholderia glumae* BGR1, evolutionarily close to groups I and II strains, also has the *bce* gene clusters into different genomic locations.

![**Genes and proteins involved in cepacian biosynthesis**. **(A)** Genetic organization of *bce-I* and *bce-II* clusters of genes encoding proteins involved in cepacian biosynthesis. With exception of *B. xenovorans*, *B. phymatum*, *B. phytofirmans*, *B. graminis*, *Burkholderia* sp. H160 and sp. CCGE 1003, in most of *Burkholderia* species, the two clusters are located approximately 155--314 kb apart in the genome. **(B)** Neighbor-joining phylogenetic tree of the deduced amino acid sequences of Bce predicted proteins from 16 strains of *Burkholderia* distributed by 14 species. The several Bce protein sequences of each species were concatenated and were aligned by CLUSTALX 2.0 using 1000 bootstrap replicates and sorted by TreeView 1.6.6. The clusters obtained allow the distinction of *Bc*c strains (group I) from non-*Bc*c strains having the *bce* genes clustered separately (group II) or together (group III) in their genomes. Scale: number of substitutions per site.](fcimb-01-00016-g001){#F1}

Cepacian biosynthesis starts with the formation of activated sugar-nucleotide precursors required for the synthesis of the repeat-unit building blocks (Figure [2](#F2){ref-type="fig"}A; Richau et al., [@B37]). Several of the enzymes involved in the process are encoded within the *bce-I* and *bce-II* gene clusters. Gene *bceA* encodes a bifunctional protein providing the first and third steps (phosphomannose isomerase and GDP-[d]{.smallcaps}-mannose pyrophosphorylase activities) for converting fructose-6-phosphate from central metabolism into GDP-[d]{.smallcaps}-mannose (Figure [2](#F2){ref-type="fig"}A; Sousa et al., [@B43], [@B42]). A *bceA* gene insertion mutant was still capable of producing half the amount of EPS of the parental strain *B. cepacia* IST408, showing that other enzymes producing GDP-[d]{.smallcaps}-mannose are present in this microorganism (Sousa et al., [@B43]). Gene *bceC* encodes a UDP-glucose dehydrogenase responsible for the NAD-dependent twofold oxidation of UDP-[d]{.smallcaps}-glucose to UDP-[d]{.smallcaps}-glucuronic acid (Loutet et al., [@B26]). Its 3D-structure was recently determined and the tyrosine residue at position 10 was found to be the key catalytic residue in the final hydrolysis of the enzymatic thioester intermediate (Rocha et al., [@B38]). Although there is no experimental demonstration, *bceT* gene product must provide the activity of UDP-glucose pyrophosphorylase for the synthesis of UDP-[d]{.smallcaps}-glucose and *bceN* and *bceM* gene products provide the activities of GDP-mannose-4,6-dehydratase (GMD) and a GDP-6-deoxy-[d]{.smallcaps}-*lyxo*-4-hexulose reductase (RMD) for GDP-[d]{.smallcaps}-rhamnose synthesis (Figure [2](#F2){ref-type="fig"}A; Ferreira et al., [@B16]). The genes encoding the enzymes UDP-glucose epimerase required for the formation of UDP-[d]{.smallcaps}-galactose and phosphoglucomutase (PGM), phosphoglucose isomerase (PGI), and phosphomannomutase (PMM) required for the synthesis of some of the intermediary precursors are absent from *bce*-I and *bce*-II gene clusters. Since the products of these enzymatic reactions are involved in other polysaccharide biosynthetic pathways, these enzyme-encoding genes are located elsewhere in the genome. *In silico* analysis using *B. cenocepacia* J2315 genome sequence shows that BCAL3113 encodes an enzyme with the putative function of PGM and PMM; BCAL1990 encodes the putative PGI enzyme; and BCAL3117 encodes a putative UDP-glucose epimerase.

![**Biosynthesis of the exopolysaccharide cepacian by *Burkholderia***. **(A)** Metabolic route toward the synthesis of the various activated sugar-nucleotide precursors required for cepacian repeat-unit biosynthesis. **(B)** Schematic representation of enzymes involved in cepacian biosynthesis. Repeat-units of the polymer are assembled on a isoprenoid lipid carrier, in the cytoplasmic side of inner membrane in a reaction initiated by the BceB enzyme and continued by the other glycosyltransferases BceG, BceH, BceJ, BceK, and BceR and putative acyltransferases BceO, BceS and BceU. The lipid-linked repeat-units are translocated across the inner membrane by the putative BceQ membrane protein. Polymerization occurs at the periplasmic face of the inner membrane and is dependent on another membrane protein, the putative polysaccharide polymerase, BceI. Wzy-dependent polymerization/export requires the activity of the BceF tyrosine kinase. BceD is a protein tyrosine phosphatase enzyme responsible for dephosphorylating BceF. BceE forms a channel structure for export of EPS chains to the outside. BceP, putatively involved in polysaccharide degradation, is depicted as associated to the outer membrane, as one of its possible locations. Glc, glucose; GlcA, glucuronic acid; Gal, galactose; Rha, rhamnose; Man, mannose; Fru, fructose; GDP, guanosine-5′-diphosphate; UDP, uridine-5′-diphosphate; PGM, phosphoglucomutase; UGP, UDP-glucose pyrophosphorylase; UGD, UDP-glucose dehydrogenase; UGE, UDP-glucose epimerase; PGI, phosphoglucose isomerase; PMI, phosphomannose isomerase; PMM, phosphomannomutase; GMP, GDP-D-mannose pyrophosphorylase; GRS, GDP-rhamnose synthase; ATP, adenosine-5′- triphosphate; ADP, adenosine-5′- diphosphate; Y^P^, phosphorylated tyrosine residue; Pi, inorganic phosphate; IM, inner membrane; OM, outer membrane; PL, peptidoglycan layer.](fcimb-01-00016-g002){#F2}

The synthesis of the activated sugar-nucleotide precursors is followed by the assembly of the heptasaccharide repeat-unit, catalyzed by glycosyltransferase proteins encoded by *bceB*, *bceG*, *bceH*, *bceJ*, *bceK*, and *bceR* genes (Figure [2](#F2){ref-type="fig"}B). BceB is an inner membrane protein that catalyzes the transfer of glucose-1-phosphate to the isoprenoid lipid carrier (Videira et al., [@B50]). The specific sugar added by the remaining Bce glycosyltransferases has not yet been identified. BceG is predicted to belong to the CAZy GT-2 family of enzymes that transfer glycosyl residues by an inverting mechanism and adopt a GT-A fold having a single Rossmann-like domain for nucleotide binding (Coutinho et al., [@B12]). BceH, BceJ, and BceK are predicted to belong to CAZy GT-1 family, which comprises retaining glycosyltransferases that adopt a GT-B fold characteristic of proteins that have two Rossmann-like domains. The protein encoded by *bceR* gene is predicted to be a bifunctional enzyme with two glycosyltransferase domains of CAZy GT-4 family with a retaining mechanism of glycosyl residue transfer and adopting a GT-B fold. BceR has been shown to be essential for cepacian biosynthesis, as confirmed by the absence of exopolysaccharide in the growth medium of *B. cepacia* IST408 *bceR* gene insertion mutant (Ferreira et al., [@B16]). BceG, BceH, and BceR are probably cytoplasmic proteins, whereas BceJ and BceK are likely to possess a transmembrane domain, being integral membrane proteins. The order of sugar addition to the repeat-unit has been proposed (Cescutti et al., [@B8]) with the glucuronic acid being added to a trisaccharide composed of glucose and mannose substituted with galactose; then a second galactose is added to the glucuronic acid as the first substituent, followed by a rhamnose and galactose, as a second disaccharide substituent (Cescutti et al., [@B8]). Cepacian acetylation is predicted to occur during the repeat-unit assembly process, but the number of substitutions is strain dependent (Cescutti et al., [@B8]). The enzymes required for these modifications are putatively encoded by *bceS*, *bceT*, and *bceU* genes and are predicted to be located in the inner membrane. BceO and BceU exhibit nine predicted transmembrane domains, while BceS exhibits eight predicted transmembrane domains (Figure [2](#F2){ref-type="fig"}B; Ferreira et al., [@B16]). Despite a weak conservation at the amino acid level, BceO, BceS, and BceU are homologous to a series of proteins that define a family of membrane proteins involved in the acylation of carbohydrate moieties of extracytoplasmic molecules. An insertion mutant on *bceS* gene showed a reduction of the acetylation content of the EPS produced by *B. multivorans* ATCC 17616 by approximately 20%, which confirms BceS involvement in the repeat-unit modification (Ferreira et al., [@B16]).

The steps after repeat-unit assembly are polymerization and export of the exopolysaccharide to the cell's surrounding. Available data indicates the assembly proceeds via the so-called Wzy-dependent pathway (Figure [2](#F2){ref-type="fig"}B). According to this model, the lipid carrier-linked heptasaccharide repeat-units are exported across the inner membrane by a flippase protein and polymerized at the periplasmic face of the inner membrane by a polysaccharide polymerase. Since the proteins encoded by *bceQ* and *bceI* genes, have 12 and 10 transmembrane domains, respectively, and show similarity with other Wzx flippases and Wzy polysaccharide polymerases, we postulated that BceI is the putative polymerase and BceQ the putative flippase. Both genes are essential for cepacian biosynthesis, as demonstrated by the EPS deficient phenotype of the *B. cepacia* IST408 insertion mutants for *bceI* and *bceQ* genes (Moreira et al., [@B30]; Ferreira et al., [@B16]). The proteins encoded by *bceD* and *bceF* genes are also involved in the EPS polymerization and export process (Figure [2](#F2){ref-type="fig"}B). BceF belongs to the bacterial tyrosine kinase (BY-kinase) family which includes Wzc homologs predicted to act as the polysaccharide copolymerase component (Whitfield, [@B52]). BceF possesses two transmembrane domains that flank a large periplasmic domain and a cytoplasmic located C-terminal region. The periplasmic domain is predicted to adopt a coiled-coil structure important for interaction with other protein (such as BceE). Tocilj et al. ([@B47]) propose that this periplasmic domain is the one affecting polysaccharide chain length, and that by interacting with the export component facilitates transfer of the polymer through the periplasm. The C-terminal cytoplasmic domain of BceF has the conserved Walker A and Walker B ATP-binding motifs and a tyrosine-rich cluster (Moreira et al., [@B30]; Ferreira et al., [@B17]). Site-directed mutagenesis was used to confirm the importance of the Walker A motif on BceF tyrosine autophosphorylation activity (Ferreira et al., [@B17]), but the role of tyrosine phosphorylation in cepacian biosynthesis is unknown. BceD is a phosphotyrosine phosphatase (PTP) protein that interacts with BceF, promoting the BY-kinase tyrosine dephosphorylation (Ferreira et al., [@B17]). BceE is a putative Wza homolog and therefore is predicted to be an outer membrane polysaccharide export protein (OPX) responsible for the final stage of polysaccharide export. OPX family of proteins are predicted to be lipoproteins that adopt an octameric configuration with a large central cavity that facilitates polysaccharide export through the periplasm and across the outer membrane (Dong et al., [@B15]). A *B. cepacia* IST408 *bceE* mutant is impaired in cepacian biosynthesis demonstrating the importance of this protein in the biosynthesis of this polymer (our unpublished data). Finally, *bce*-II gene cluster contains the *bceP* gene, encoding a protein of unknown function. BceP secondary structure was predicted to be exclusively composed of β-strands, and its location is unlikely the cytoplasm. It can be the periplasm, the outer membrane, or even the extracellular milieu. Structural homology modeling suggests that BceP resembles polysaccharide degrading enzymes such as *Clostridium thermocellum* xyloglucanase (PDB entry: 2cn2). Thus, BceP may be responsible for processing the polysaccharide before and/or after export depending on its cellular localization.

Regulation of Cepacian Biosynthesis
===================================

Although the *bce*-I and *bce*-II gene clusters encode most of the structural proteins required for cepacian biosynthesis, the genes directly involved in the regulation of EPS production have not been identified. While *algU* and *mucA* genes encode a transcription factor and anti-sigma factor, respectively, responsible for the control of the alginate biosynthetic operon in *Pseudomonas aeruginosa* (Ramsey and Wozniak, [@B35]), the *B*. *cepacia* AlgU homolog (RpoE) is not required for exopolysaccharide biosynthesis as demonstrated for a *rpoE* knockout mutant (Devescovi and Venturi, [@B14]). Although the mechanisms/players involved in the regulation of cepacian biosynthesis are unclear, there are evidences of the involvement of quorum sensing (QS) regulation at transcriptional level and protein tyrosine phosphorylation/dephosphorylation at post-translational level.

Recent studies on the plant-associated *B. kururiensis* M130, *B. xenovorans* LB400, and *B. uname* MTI-641 indicate that the *N*-acyl homoserine lactones (AHL) synthase BraI and the QS transcriptional regulator BraR are involved in the regulation of EPS biosynthesis. The mutants obtained for *braI* and *braR* genes were less mucoid and the total sugar content of the growth culture decreased considerably (Suarez-Moreno et al., [@B46]). This phenotype could be reversed by external supplementation of 3-oxo-C14-HSL or 3-oxo-C12-HSL, depending on the species (Suarez-Moreno et al., [@B46]). Such results confirm that QS positively controls EPS production in these plant-associated species, still the targets of such regulation cascade are unknown. Furthermore, the BraI/R system is not conserved in the *Burkholderia* genus and 3-oxo-AHLs are not produced by many species. For instance, in *Bc*c bacteria, the most well conserved QS system consists of CepI and CepR which produces and responds to C6-HSL and C8-HSL (Sokol et al., [@B41]). Whether CepI/CepR system mediated QS is able to regulate EPS production in the different *Bc*c species still needs confirmation.

Another mechanism that may be involved in regulating cepacian biosynthesis at the transcriptional level is mediated by the RNA chaperone Hfq. This protein is involved in the regulation of target mRNAs by small regulatory non-coding RNAs (Sousa et al., [@B45]). Deletion of *hfq* gene of *B. cepacia* IST408 strongly reduces cepacian production. Whether a small RNA molecule is directly responsible for this phenotype or is a consequence of the pleiotropic effects caused by loss of this gene still has to be determined.

Regarding post-translational regulation, it is established that cycles of tyrosine phosphorylation and dephosphorylation, mediated by BY-kinases and PTP proteins, control the amount and the molecular weight of several bacterial exopolysaccharides (Vincent et al., [@B51]; Wugeditsch et al., [@B53]). However, the exact mechanism of such regulation is not clear. One hypothesis is that the BY-kinase tyrosine phosphorylation/dephosphorylation cycles interfere with the interaction with the outer membrane export OPX proteins by introducing conformational changes in the BY-kinase/OPX complex, perhaps affecting polymerization and/or export of the polysaccharide to the cell surrounding (Collins et al., [@B10]). Alternatively, BY-kinases may phosphorylate exogenous substrates, including proteins involved in sugar-nucleotide precursor's formation and repeat-unit assembly, thereby controlling their activity and consequently polysaccharide production. This was shown for colanic acid biosynthesis in *E. coli* in which the UDP-glucose dehydrogenase protein is phosphorylated by the Wzc BY-kinase, influencing the amount of EPS (Lacour et al., [@B24]). In *Streptococcus thermophilus* the EPS priming glycosyltransferase EpsE was shown to be regulated by the tyrosine kinase EpsD (Minic et al., [@B29]). Concerning cepacian biosynthesis, the disruption of the *bceF* gene abolishes cepacian production, while the *bceD* mutant shows a reduction of about 25% of cepacian production, and the EPS has a lower molecular weight than that produced by the parental strain (Ferreira et al., [@B17]). Therefore, BceF BY-kinase and BceD PTP protein may be involved in the regulation of the amount and molecular weight of cepacian, even though there are no studies available regarding their exact role in polymerization/export or in regulating the activity of the enzymes involved in sugar-nucleotide precursors biosynthesis and repeat-unit assembly.

Role of *Burkholderia* Exopolysaccharides in Adaptation to Different Niches
===========================================================================

Bacterial extracellular polysaccharides have been described as pathogenicity determinants in humans, livestock, and plant infections; as important in the establishment of symbiotic interactions between bacteria and plants; and as a barrier to harmful compounds (Fraysse et al., [@B18]; Lebeer et al., [@B25]; Nielsen et al., [@B31]). Depending on the ecological niche, exopolysaccharides help bacteria to colonize different environments. Given that cepacian is ubiquitous in the genus *Burkholderia*, it would be expected that this EPS plays an important role in bacterial adaptation to different conditions including host/bacteria interactions. Figure [3](#F3){ref-type="fig"} summarizes the current knowledge on the relevance of exopolysaccharides in *Burkholderia* biology. Interaction between plants and bacteria is often correlated to the ability of bacteria to produce EPSs, regardless being pathogenic or symbiotic. In pathogenic interactions, EPS contributes to the initial plant colonization and enhances bacteria survival within the plant host tissues during the course of infection, as described for *Agrobacterium*, *Erwinia*, and *Pseudomonas* (Denny, [@B13]). On the other hand, EPSs are important in the establishment of symbiotic interactions such as in biological nitrogen fixation symbiosis between rhizobia and leguminous plants (Gonzalez et al., [@B19]). Since the first description of pathogenicity in the *Bc*c bacteria was based on sour skin rot of onion bulbs, Bartholdson et al. ([@B1]) investigated EPS production in *Bc*c isolates and their onion-associated phenotype. Although the onion carbohydrates induced EPS production, no correlation between exopolysaccharide production ability of the tested strains and tissue onion maceration was found. Therefore, a possible role of the exopolysaccharides in interaction between *Burkholderia* and host plants has yet to be demonstrated. Nevertheless, the observation that the endophytic *B. kururiensis* exopolysaccharides can be modulated under growth conditions is potentially significant in terms of a possible endophytic-host plant interaction and further studies are needed (Hallack et al., [@B21]).

![**Roles of *Burkholderia* exopolysaccharides in the adaptation to different niches**.](fcimb-01-00016-g003){#F3}

Since many exopolysaccharides are high-molecular weight polymers, they form a hydrated anionic matrix that surrounds the cell protecting bacteria against environmental stresses. Also, the hygroscopic properties of the EPS may reduce the rate of water loss from cells and provide bacteria with means to survive drying and desiccation (Potts, [@B34]). A study performed with *B. xenovorans* LB400 and *B. multivorans* ATCC 17616 isolates has shown that the external supplementation of cepacian enhanced their desiccation tolerance when compared to a condition where no exopolysaccharide was present (Ferreira et al., [@B16]). Cepacian also protects *Burkholderia* cells against metal ion stress, namely high concentration of Fe^2+^ and Zn^2+^ (Ferreira et al., [@B16]). The metal-binding properties of EPS might be due to the occurrence of carbonyl, carboxyl, and hydroxyl groups within the EPS matrix that can complex cations and scavenge metals (Potts, [@B34]). The ability of *Burkholderia* strains to withstand desiccation and metal ion stress in the presence of the cepacian is an indication that this EPS may play a role in survival, thus representing an advantage for bacteria to thrive in adverse environments.

Exopolysaccharides influence the stability of soil aggregates by interacting with clay particles contributing to maintain the mechanical and physical properties of the soil on which plant roots are grown. Vanhaverbeke et al. ([@B49]) used the exopolysaccharide produced by *Burkholderia caribensis* MWAP71 to determine the interactions between the polysaccharide and the soil at the molecular level and one of the hypothesis raised is that the disorganized conformations of the exopolysaccharide connects several clay layers, resulting in a network composed by clays partially dispersed within an EPS matrix, which enhances the hydration properties of the whole soil.

*Burkholderia* exopolysaccharides, particularly cepacian, was postulated as a virulence determinant of *Bc*c species infecting the airways of cystic fibrosis (CF) patients and its importance in pathogenicity was assessed by several *in vitro* and *in vivo* studies. For instance, infection of a BALB/c mouse pulmonary infection model with two clonal isolates of *B. cenocepacia* obtained from a CF patient and displaying a different morphotype (mucoid vs. non-mucoid) showed that the mucoid isolate persisted longer in the lungs (Conway et al., [@B11]). Similarly, the infection of the gp91^phox−/−^ mouse with EPS-producing bacteria of the species *B*. *cepacia* showed that the EPS-producing strain *B. cepacia* IST408 caused higher mice mortality than the non-EPS producer isogenic *bceF* and *bceI* mutants (Sousa et al., [@B44]). *In vitro* studies confirmed the ability of *Burkholderia* exopolysaccharides to interfere with the innate immune system by neutralizing reactive oxygen species (Bylund et al., [@B3]), inhibiting neutrophil chemotaxis and interfering with phagocytosis of bacteria by human neutrophils (Conway et al., [@B11]; Bylund et al., [@B3]). The interference by the EPS in phagocytosis could possibly be explained by the masking of bacterial surface antigens recognized by immune cells. Although these data suggest that exopolysaccharides enhance bacterial virulence, there is no experimental demonstration of *Bc*c bacteria producing it within the lungs. In addition, EPSs are not the only virulence factor in *Bc*c since the most hostile strains, responsible for major clinical outbreaks and associated to a worst clinical outcome that includes the development of cepacia syndrome, are non-mucoid (Govan et al., [@B20]). Supporting this, a recent surveillance study showed that patients infected with non-mucoid *Bc*c strains experience a more rapid lung function decline (Zlosnik et al., [@B54]). Still, most of the clinical isolates from different *Bc*c species, with the exception of *B. cenocepacia*, are able to produce exopolysaccharide (Zlosnik et al., [@B55]).

Another import role attributed to polysaccharides is the mediation of bacterial resistance against antimicrobial peptides produced by epithelial and phagocytic cells. A study involving the human antimicrobial peptides cathelicidin LL-37 and β-defensin hBD-3 as well as peptides from other mammals demonstrated that the antibacterial activity of these different peptides was considerably decreased in the presence of polysaccharides produced by the lung pathogens *P. aeruginosa*, *Klebsiella pneumoniae*, and *Bc*c members (Benincasa et al., [@B2]). Production of bacterial polysaccharides in the lungs of CF patients could contribute to a decreased efficacy of the host defense response and the concomitant establishment of a persistent infection by these bacteria.

Exopolysaccharides, proteins, and DNA are the main constituents of the mature biofilm matrix contributing for example to the persistence of chronic *P. aeruginosa* lung infections in CF patients (Hentzer et al., [@B22]). Bacterial biofilms cause chronic infections due to their increased tolerance to antibiotics and resistance to the immune system phagocytic cells. As a consequence, chronic inflammation develops, being the major cause of the lung tissue damage in CF (Hoiby et al., [@B23]). *Bc*c bacteria were also shown to produce biofilms in abiotic surfaces and on well-differentiated human epithelial cells (Schwab et al., [@B39]) and the production of biofilms associated to a significant increase of resistance against the host immune system and antibiotic treatment in *Burkholderia* (Caraher et al., [@B4]). Mutants constructed on *bce* genes have confirmed the importance of cepacian in the formation of mature biofilms. Mutants unable to produce cepacian, such as a *bceF* insertion mutant, or mutants that produce a lower molecular weight form, such as *bceD* insertion mutant, exhibited a much thinner biofilm when compared to the one produced by the parental strain (Ferreira et al., [@B17]). Therefore, it has been hypothesized that by promoting the formation of mature biofilms, the EPS may enhance bacterial survival in CF lung, which leads to the impossibility to efficiently eradicate *Bc*c infections.

Emergence of *Burkholderia* Morphotype Variation during Chronic Lung Infections
===============================================================================

The initial colonization of CF lungs by *P. aeruginosa* is made by environmental strains that during the course of infection developed the mucoid phenotype caused by production of alginate (Pedersen et al., [@B33]). To evaluate whether *Burkholderia* shows such variation during lung colonization, 560 *Bc*c sequential isolates recovered from 100 CF patients were screened for EPS production by analyzing their mucoid phenotype in EPS-producing medium (Zlosnik et al., [@B55]). Fifteen mucoid phenotypic transitions were observed: 13 from mucoid-to-non-mucoid were detected in *B. multivorans*, *B. cenocepacia*, and *B. vietnamiensis*; and two non-mucoid-to-mucoid transitions occurred in *B. cenocepacia* and *B. vietnamiensis* (Zlosnik et al., [@B55]). Further insights into the importance of this morphotypic variation in adaptation to lung environment came from two pairs of sequential isolates recovered from patients chronically infected for several years. The first pair of sequential isolates characterized was from *B. cenocepacia* and the isolates were recovered within 10 months of each other (Conway et al., [@B11]). These isolates showed genomic alterations as visible by their genome *Spe*I-restriction pattern, by mutations in the QS regulator encoding gene *cepR* and deletion of a region from the pathogenicity island present in the mucoid isolate (Zlosnik and Speert, [@B56]; McKeon et al., [@B28]). In addition, the mucoid isolate had decreased expression of virulence factors such as the nematocidal protein AidA or the zinc metalloprotease ZmpA, was less resistant to oxidative stress, produced less biofilm, but showed a lower clearance rate from the lungs of BALB/c mice when compared to the clonal non-mucoid isolate (Conway et al., [@B11]; Zlosnik and Speert, [@B56]). The second pair of clonal sequential isolates belongs to *B. multivorans* and the isolates recovered within a 6-month period. The mucoid isolate had decreased long-term survival rate in nutrient depleted medium, produced less biofilm, had increased expression of virulence-associated genes, higher growth rate under microaerophilic conditions, increased motility, and was shown to be more virulent in *Galleria mellonella* (Silva et al., [@B40]). Since only two pairs of isolates with a mucoid vs. non-mucoid morphotype were evaluated it is early to take conclusions about the typical phenotypic profile of the non-mucoid isolates arising during chronic respiratory lung infections. Nevertheless, it is evident that the emergence of mucoid vs. non-mucoid morphotype variation in the lung of CF patients is correlated with metabolic changes, different survival ability under stress conditions, altered biofilm formation, motility, chemotaxis, and virulence (Figure [4](#F4){ref-type="fig"}).

![**Bacterial phenotypes displaying variation during *Bc*c mucoid vs. non-mucoid transition that occurs in persistently colonized lungs of cystic fibrosis patients**.](fcimb-01-00016-g004){#F4}

The relationship of mucoid morphotype variation within adaptation to the lung environment and disease progression is not yet known. If EPS-producing bacteria could be favored to persist in the lungs by avoiding the immune system, it is also true that the non-EPS producers, by their ability to produce more biofilm and displaying higher survival rate under nutrient limitation, may be adapted as well to persist in the lungs. As regards the virulence potential of the mucoid and non-mucoid clonal isolates, the data obtained so far for mice and insects showed that the mucoid isolates were more virulent (Conway et al., [@B11]; Silva et al., [@B40]). Nevertheless, these data report to two isolates only and no ultimate conclusion about their virulence potential can be made. Besides, a study focused on the virulence potential of mucoid and non-mucoid clinical isolates in CF patient's lung function decline, suggested that patients infected with non-mucoid isolates had worst prognosis (Zlosnik et al., [@B54]).

The cues triggering mucoid morphotype variation of *Bc*c during their persistence in the CF lung remain unknown. The only *in vitro* condition described so far that induces *B. cenocepacia* mucoid vs. non-mucoid transition is high doses of the antibiotics ceftazidime and ciprofloxacin (Zlosnik et al., [@B54]). As regards the molecular mechanisms behind the morphotype variation they are completely unidentified. During chronic lung infection genomic alterations including point mutations, deletion, and duplication of genes arise as it was found for the two pairs of *Bc*c isolates where the mucoid morphotype variation was characterized (Zlosnik and Speert, [@B56]; Silva et al., [@B40]). Whether these alterations are responsible for the observed phenotypes is unknown.

Concluding Remarks
==================

The genus *Burkholderia* has the genetic capacity to produce several different secreted extracellular polysaccharides, although only cepacian biosynthetic mechanisms have been studied with some detail by the identification of the genes involved and characterization of some of the Bce proteins. However, no information exists regarding genetics and regulation of other polysaccharides identified in *Burkholderia*, some of which are often coexpressed with cepacian. The ability of *Burkholderia* to produce different exopolysaccharides raises questions on which environmental signals induce production of one polysaccharide vs. others and their specific roles to provide a survival advantage in different ecological niches such as soil, water, or during host/bacteria interactions. In particular, efforts have been made to understand the relevance of EPS production in virulence and persistence of *Bc*c bacteria in CF lung, but the role of EPS in *Burkholderia* virulence remains an open issue. While some evidences point out to EPS as a virulence factor, others indicate a major role in persistence. Furthermore, during the course of chronic lung infection genotypic and mucoid morphotype variation occurs, with clonal isolates displaying different phenotypes and virulence levels. This shows that EPS biosynthesis can be critical during *Burkholderia* lung infection, likely as part of a complex regulation network interfering with many other bacterial properties that change during infection and represent important bacterial adaptations to the CF lung. Further research is needed to understand the conditions that trigger such phenotypic conversions as well as the regulatory mechanisms underlying the cepacian biosynthesis.
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